REGULATORY NEWS
FDA clears Zoll hospital defibrillators
|
Written by Editorial Staff
January 29, 2009
FURTHER READINGTopicOrganizationCompanyPortalsSection    The Chelmsford, Mass.-based company said its new R Series BLS and R Series Plus are designed to extend defibrillation to hospital departments with solutions for resuscitation. The R Series BLS is an AED that becomes a life-support device. The R Series Plus, which has both AED and ALS capabilities, also has networking capabilities and See-Thru CPR, which allows the professional rescuer to view a patient’s underlying cardiac rhythm during resuscitation efforts without the need to stop compressions. The models provide the Real CPR Help feature that provides feedback on the rate and depth of chest compressions. Both the BLS and Plus models have CE Mark and are available in English, French, Italian, German, Danish and Finnish. Based on WiFi technology, the R Series sends a status of its state of readiness at a programmed time. Early notification maximizes patient safety by letting the clinician intervene before the defibrillator is needed for a code, Zoll said.
Last updated on February 2, 2009 at 4:36 pm EST
|
